Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Clinical Trials Management
1358
mi
from 02139
Metairie, LA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Clinical Trials Management
1358
mi
from 02139
Metairie, LA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive Disorders Associates
365
mi
from 02139
Annapolis, MD
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive Disorders Associates
365
mi
from 02139
Annapolis, MD
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Alan Rosen, M.D.
357
mi
from 02139
Baltimore, MD
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Alan Rosen, M.D.
357
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive Disease Association
362
mi
from 02139
Baltimore, MD
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive Disease Association
362
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Metro Gastroenterology Group
391
mi
from 02139
Chevy Chase, MD
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Metro Gastroenterology Group
391
mi
from 02139
Chevy Chase, MD
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Washington County Hospital
393
mi
from 02139
Hagerstown, MD
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Washington County Hospital
393
mi
from 02139
Hagerstown, MD
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Philip J. Bean Medical Center
400
mi
from 02139
Hollywood, MD
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Philip J. Bean Medical Center
400
mi
from 02139
Hollywood, MD
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Charm City Research
353
mi
from 02139
Lutherville, MD
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Charm City Research
353
mi
from 02139
Lutherville, MD
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Coastal Research Associates, Inc.
11
mi
from 02139
Braintree, MA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Coastal Research Associates, Inc.
11
mi
from 02139
Braintree, MA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Clinical Research Institute of Michigan,
613
mi
from 02139
Chesterfield, MI
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Clinical Research Institute of Michigan,
613
mi
from 02139
Chesterfield, MI
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Gastroenterology Associates of West Michigan
737
mi
from 02139
Grand Rapids, MI
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Gastroenterology Associates of West Michigan
737
mi
from 02139
Grand Rapids, MI
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Gastrointestinal Associates, P.A.
1252
mi
from 02139
Jackson, MS
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Gastrointestinal Associates, P.A.
1252
mi
from 02139
Jackson, MS
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Center for Digestive & Liver Diseases Inc.
1106
mi
from 02139
Mexico, MO
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Center for Digestive & Liver Diseases Inc.
1106
mi
from 02139
Mexico, MO
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
St Louis Center For Clinical Research
1046
mi
from 02139
Saint Louis, MO
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
St Louis Center For Clinical Research
1046
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Central Jersey Medical Research
199
mi
from 02139
Elizabeth, NJ
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Central Jersey Medical Research
199
mi
from 02139
Elizabeth, NJ
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Shore Health Group
211
mi
from 02139
Ocean City, NJ
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Shore Health Group
211
mi
from 02139
Ocean City, NJ
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
The GI Group of South Jersey
287
mi
from 02139
Vineland, NJ
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
The GI Group of South Jersey
287
mi
from 02139
Vineland, NJ
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Long Island Clinical Research
173
mi
from 02139
Great Neck, NY
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Long Island Clinical Research
173
mi
from 02139
Great Neck, NY
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
New York Presbyterian Hospital: Weill Medical College of Cornell University
184
mi
from 02139
New York, NY
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
New York Presbyterian Hospital: Weill Medical College of Cornell University
184
mi
from 02139
New York, NY
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Simon Lichtiger, M.D.
183
mi
from 02139
New York, NY
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Simon Lichtiger, M.D.
183
mi
from 02139
New York, NY
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Stony Brook University Hospital
127
mi
from 02139
Stony Brook, NY
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Stony Brook University Hospital
127
mi
from 02139
Stony Brook, NY
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Charlotte Gastroenterology and Hepatology
719
mi
from 02139
Charlotte, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Charlotte Gastroenterology and Hepatology
719
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Northwest Piedmont Clinical Research
713
mi
from 02139
Elkin, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Northwest Piedmont Clinical Research
713
mi
from 02139
Elkin, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
LeBauer Research Associates
637
mi
from 02139
Greensboro, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
LeBauer Research Associates
637
mi
from 02139
Greensboro, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Carolina Digestive Diseases
574
mi
from 02139
Greenville, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Carolina Digestive Diseases
574
mi
from 02139
Greenville, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
East Carolina Gastroenterology
626
mi
from 02139
Jacksonville, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
East Carolina Gastroenterology
626
mi
from 02139
Jacksonville, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Wake Research Associates, LLC
606
mi
from 02139
Raleigh, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Wake Research Associates, LLC
606
mi
from 02139
Raleigh, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Hanover Medical Specialists
672
mi
from 02139
Wilmington, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Hanover Medical Specialists
672
mi
from 02139
Wilmington, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Wilmington Gastroenterology Associates
672
mi
from 02139
Wilmington, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Wilmington Gastroenterology Associates
672
mi
from 02139
Wilmington, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive Health Specialists, Pa
658
mi
from 02139
Winston-salem, NC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive Health Specialists, Pa
658
mi
from 02139
Winston-salem, NC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Gastroenterology Specialists, Inc.
542
mi
from 02139
Canton, OH
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Gastroenterology Specialists, Inc.
542
mi
from 02139
Canton, OH
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Consultants for Clinical Research Inc.
735
mi
from 02139
Cincinnati, OH
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Consultants for Clinical Research Inc.
735
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive Health Newtork
735
mi
from 02139
Cincinnati, OH
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive Health Newtork
735
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Gastrointestinal & Liver Disease Consultants
702
mi
from 02139
Dayton, OH
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Gastrointestinal & Liver Disease Consultants
702
mi
from 02139
Dayton, OH
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Avamar Center for Endoscopy
506
mi
from 02139
Warren, OH
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Avamar Center for Endoscopy
506
mi
from 02139
Warren, OH
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Sooner Clinical Research
1491
mi
from 02139
Oklahoma City, OK
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Sooner Clinical Research
1491
mi
from 02139
Oklahoma City, OK
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Gastroenterology United of Tulsa
1391
mi
from 02139
Tulsa, OK
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Gastroenterology United of Tulsa
1391
mi
from 02139
Tulsa, OK
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
George Koval, M.D.
2535
mi
from 02139
Portland, OR
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
George Koval, M.D.
2535
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Penn State Milton S. Hershey Medical Center
321
mi
from 02139
Hershey, PA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Penn State Milton S. Hershey Medical Center
321
mi
from 02139
Hershey, PA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Thomas Jefferson University
268
mi
from 02139
Philadelphia, PA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Thomas Jefferson University
268
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Guthrie Clinic, Ltd.
278
mi
from 02139
Sayre, PA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Guthrie Clinic, Ltd.
278
mi
from 02139
Sayre, PA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Charleston Gastroenterology Center
820
mi
from 02139
Charleston, SC
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Charleston Gastroenterology Center
820
mi
from 02139
Charleston, SC
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
ClinSearch, LLC
909
mi
from 02139
Chattanooga, TN
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
ClinSearch, LLC
909
mi
from 02139
Chattanooga, TN
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Memphis Gastroenterology Group
1121
mi
from 02139
Memphis, TN
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Memphis Gastroenterology Group
1121
mi
from 02139
Memphis, TN
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Gastrointestinal Institute, PLLC
941
mi
from 02139
Nashville, TN
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Gastrointestinal Institute, PLLC
941
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Nashville Medical Research Institute
945
mi
from 02139
Nashville, TN
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Nashville Medical Research Institute
945
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Austin Gastroenterology, PA
1690
mi
from 02139
Austin, TX
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Austin Gastroenterology, PA
1690
mi
from 02139
Austin, TX
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Nationsmed Clinical Research
1601
mi
from 02139
Houston, TX
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Nationsmed Clinical Research
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Houston Digestive Diseases Clinic
1594
mi
from 02139
Houston, TX
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Houston Digestive Diseases Clinic
1594
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Houston Medical Research Associates
1601
mi
from 02139
Houston, TX
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Houston Medical Research Associates
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials